Literature DB >> 10176783

On valuing morbidity, cost-effectiveness analysis, and being rude.

D Kenkel1.   

Abstract

Mesh:

Year:  1997        PMID: 10176783     DOI: 10.1016/s0167-6296(97)00027-1

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


× No keyword cloud information.
  10 in total

Review 1.  Willingness to pay and the valuation of programmes for the prevention and control of influenza.

Authors:  S Birch; A Gafni; B O'Brien
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

Review 2.  On individual preferences and aggregation in economic evaluation in healthcare.

Authors:  B Liljas; B Lindgren
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

3.  Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI.

Authors:  Michael T French; Helena J Salomé; Jody L Sindelar; A Thomas McLellan
Journal:  Health Serv Res       Date:  2002-04       Impact factor: 3.402

4.  Willingness to pay. What's in a name?

Authors:  A Gafni
Journal:  Pharmacoeconomics       Date:  1998-11       Impact factor: 4.981

5.  Creating an aggregate outcome index: cost-effectiveness analysis of substance abuse treatment.

Authors:  Mireia Jofre-Bonet; Jody L Sindelar
Journal:  J Behav Health Serv Res       Date:  2004 Jul-Sep       Impact factor: 1.505

Review 6.  Clarifying efficiency-equity tradeoffs through explicit criteria, with a focus on developing countries.

Authors:  Chris James; Guy Carrin; William Savedoff; Piya Hanvoravongchai
Journal:  Health Care Anal       Date:  2005-03

7.  Costs of alcohol and drug-involved crime.

Authors:  Ted R Miller; David T Levy; Mark A Cohen; Kenya L C Cox
Journal:  Prev Sci       Date:  2006-12

8.  The calculation and use of economic burden data.

Authors:  K D Frick; S M Kymes
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

9.  Eliciting patients' values by use of 'willingness to pay': letting the theory drive the method.

Authors:  C Donaldson
Journal:  Health Expect       Date:  2001-09       Impact factor: 3.377

10.  Urge incontinence. Quality of life and patients' valuation of symptom reduction.

Authors:  R M O'Conor; M Johannesson; S L Hass; G Kobelt-Nguyen
Journal:  Pharmacoeconomics       Date:  1998-11       Impact factor: 4.981

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.